Given Rises to 5-Month High as Patients Enroll in Pillcam Trial
Stock Chart for Given Imaging Ltd (GIVN)
Given Imaging Ltd. (GIVN) advanced to the highest in more than five months after the maker of a pill-sized camera to diagnose digestive ailments said about 700 patients have enrolled in a PillCam COLON 2 trial.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.